Current Neuro-Oncology

Volume 25 Number 7
15 April 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 7, 15 April

Haider AS, Ene CI, Palmisciano P, Haider M, Rao G, Ballester LY, Fuller GN.
Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report.
Front Oncol. 2023 Apr 3;13:1071792
. doi: 10.3389/fonc.2023.1071792. PMID: 37077830. Case report. ˍ

Goddard J, Castle J, Southworth E, Fletcher A, Crosier S, Martin-Guerrero I, García-Ariza M, Navajas A, Masliah-Planchon J, Bourdeaut F, Dufour C, Ayrault O, Goschzik T, Pietsch T, Sill M, Pfister SM, Rutkowski S, Richardson S, Hill RM, Williamson D, Bailey S, Schwalbe EC, Clifford SC, Hicks D.
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Acta Neuropathol. 2023 Apr 4
. doi: 10.1007/s00401-023-02566-0. PMID: 37014508. Laboratory investigation, Observational study. ˍ

Kim MJ, Park JS, Jeun SS, Ahn S.
A clinical evaluation of cystic features in patients with newly diagnosed glioblastoma with IDH-wildtype.
Clin Neurol Neurosurg. 2023 Apr 4;228:107708
. doi: 10.1016/j.clineuro.2023.107708. PMID: 37043844. Observational study. ˍ

Moraes FY, Gouveia AG, Marta GN, Viani GA.
Radiotherapy combined or not with chemotherapy in adult or pediatric patients with brainstem glioma: a population-based study.
Rep Pract Oncol Radiother. 2023 April 4;28(2):181-188. doi: 10.5603/RPOR.a2023.0016. PMID: 37456697. Observational study. ˍ

Allwohn L, Wolfgang J, Onken J, Wasilewski D, Roohani S, Zips D, Ehret F, Kaul D.
Treating oligodendroglioma - An analysis of a homogeneous 1p/19q-codeleted and isocitrate dehydrogenase-mutant patient cohort.
Clin Transl Radiat Oncol. 2023 Apr 5;41:100626
. doi: 10.1016/j.ctro.2023.100626. PMID: 37216045. Observational study. ˍ

Jones C, Straathof K, Fouladi M, Hargrave D, Prados M, Resnick A, Doz F, Jones DTW, Mueller S.
Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks.
Front Oncol. 2023 Apr 5;13:1167082
. doi: 10.3389/fonc.2023.1167082. PMID: 37091147. Perspective. ˍ

Ma X, Liu J.
Predictive value of MRI features on glioblastoma.
Eur Radiol. 2023 Apr 5
. doi: 10.1007/s00330-023-09535-x. PMID: 37020071. Editorial. ˍ
REFERS TO: Kim M, et al. Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort. Eur Radiol. 2022 Oct 15. doi: 10.1007/s00330-022-09164-w. PMID: 36242633. Interventional study˰ ˍ

S Rai HI, Agrawal D, Singh M, Kale SS.
Early Gamma Knife Therapy (Without EBRT) in Operated Patients of Glioblastoma Multiforme.
Neurol India. 2023 Apr 6;71(Supplement):S183-S188
. doi: 10.4103/0028-3886.373625? PMID: 37026351. Observational study. ˍ

Ronsley R, Triscott J, Stanek J, Rassekh SR, Lum A, Cheng S, Goddard K, McConnell D, Strahlendorf C, Singhal A, Finlay JL, Yip S, Dunham C, Hukin J.
Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review.
Childs Nerv Syst. 2023 Apr 6
. doi: 10.1007/s00381-023-05918-z. PMID: 37022464. Observational study. ˍ

Ding Y, Wang Q, Wang F, Wu N, Li J, He X, Pan H, Wang L.
TTFields Prolonged the PFS of Epithelioid Glioblastoma Patient: A Case Report.
Brain Sci. 2023 Apr 7;13(4):633
. doi: 10.3390/brainsci13040633. PMID: 37190598. Case report. ˍ

Prener M, Opheim G, Simonsen HJ, Engelmann CM, Ziebell M, Carlsen J, Paulson OB.
Delineation of Grade II and III Gliomas Investigated by 7T MRI: An Inter-Observer Pilot Study.
Diagnostics (Basel). 2023 Apr 7;13(8):1365
. doi: 10.3390/diagnostics13081365. PMID: 37189466. Interventional study. ˍ


Youssef G, Rahman R, Bay C, Wang W, Lim-Fat MJ, Arnaout O, Bi WL, Cagney DN, Chang YS, Cloughesy TF, DeSalvo M, Ellingson BM, Flood TF, Gerstner ER, Gonzalez Castro LN, Guenette JP, Kim AE, Lee EQ, McFaline-Figueroa JR, Potter CA, Reardon DA, Huang RY, Wen PY.
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy
Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
J Clin Oncol. 2023 Apr 7:JCO2201579
. doi: 10.1200/JCO.22.01579. PMID: 37027809. Observational study˰ ˍ

Msheik A, Fares Y, Hamoud M, Atat R.
Unraveling the Complexity of Multicentric Gliomas: Insights Into Chronicity and Genetic Aberrations.
Cureus. 2023 Apr 8;15(4):e37284
. doi: 10.7759/cureus.37284. PMID: 37168179. Case report. ˍ

Muller Bark J, Karpe AV, Doecke JD, Leo P, Jeffree RL, Chua B, Day BW, Beale DJ, Punyadeera C.
A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients.
Cancer Med. 2023 Apr 9
. doi: 10.1002/cam4.5857. PMID: 37031458. Interventional study. ˍ

Bartlett S, Nagaraja TN, Griffith B, Farmer KG, Van Harn M, Haider S, Hunt RJ, Cabral G, Knight RA, Valadie OG, Brown SL, Ewing JR, Lee IY.
Persistent Peri-Ablation Blood-Brain Barrier Opening After Laser Interstitial Thermal Therapy for Brain Tumors.
Cureus. 2023 Apr 10;15(4):e37397
. Doi: 10.7759/cureus.37397. PMID: 37182017. Observational study. ˍ

Halefoglu AM, Camurcuoglu E, Tanik C, Kizilkaya O, Yilmaz A.
Predictive role of magnetic resonance imaging in the distinction of isocitrate dehydrogenase (IDH) mutant grade 4 astrocytomas versus glioblastomas.
Acta Radiol. 2023 Apr 10:2841851231165282
. doi: 10.1177/02841851231165282. PMID: 37038636. Observational study˰ ˍ

Altieri R, Certo F, Pacella D, Cammarata G, Garozzo M, Broggi G, Caltabiano R, Magro G, Russo G, Cosentino S, Ippolito M, Barbagallo G.
Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
J Neurooncol. 2023 Apr 11
. doi: 10.1007/s11060-023-04305-7. PMID: 37039952. Observational study˰ ˍ

Liu V, Wetzel EA, Eldred BSC, Zapanta Rinonos S, Prins TJ, Khanlou N, Liau LM, Chong R, Nghiemphu PL, Cloughesy TF, Ellingson BM, Lai A.
A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients.
Neurooncol Adv. 2023 Apr 11;5(1):vdad036
. doi: 10.1093/noajnl/vdad036. PMID: 37152809. Observational study. ˍ

Yuile A, Lee A, Moon EA, Hudson A, Kastelan M, Miller S, Chan D, Wei J, Back MF, Wheeler HR.
PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma.
Biomedicines. 2023 Apr 11;11(4):1148
. doi: 10.3390/biomedicines11041148. PMID: 37189766. Observational study. ˍ


She L, Mao X, Su L, Liu Z.
Prognostic evaluation of patients with glioblastoma using a new score prediction model.
Eur J Surg Oncol. 2023 Apr 12:S0748-7983(23)00438-9
. doi: 10.1016/j.ejso.2023.04.001. PMID: 37076410. Observational study˰ ˍ

Syed HR, Kilburn L, Fonseca A, Nazarian J, Oluigbo C, Myseros JS, Packer RJ, Keating RF.
First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical communication.
J Neurooncol. 2023 Apr 12. doi: 10.1007/s11060-023-04269-8
. PMID: 37046110. Interventional study˰ ˍ

Cohen A, Noxon V, Dhamane A, Bruette R, Shah S, Hines DM, Alfred T, Luo X.
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer.
Thromb Res. 2023 Apr 13;226:117-126
. doi: 10.1016/j.thromres.2023.04.009. PMID: 37146438. Observational study. ˍ

Elmuti L, Amundson J, Oberman E, Kamat A, Sedig L, Lastra RR, Aldape K, Quezado M, Pratt DW, Cimino PJ, Abdullaev Z, Pytel P, Applebaum MA, Bennett JA.
Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
Int J Gynecol Pathol. 2023 Apr 13
. doi: 10.1097/PGP.0000000000000954. PMID: 37046379. Case report˰ ˍ

Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK.
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Neurooncol Adv. 2023 Apr 13;5(1):vdad032
. doi: 10.1093/noajnl/vdad032. PMID: 37114244. Observational study. ˍ

Hassan U, Amer F, Hussain M, Mushtaq S, Loya A, Abu Bakar M.
Gemistocytic Differentiation in Isocitrate Dehydrogenase Mutant Astrocytomas: A Histopathological and Survival Analysis.
Cureus. 2023 Apr 13;15(4):e37542
. doi: 10.7759/cureus.37542. PMID: 37193447. Observational study. ˍ

Wei Y, Li G, Feng J, Wu F, Zhao Z, Bao Z, Zhang W, Su X, Li J, Qi X, Duan Z, Zhang Y, Vega SF, Jakola AS, Sun Y, Carén H, Jiang T, Fan X.
Stalled oligodendrocyte differentiation in IDH-mutant gliomas.
Genome Med. 2023 Apr 13;15(1):24
. doi: 10.1186/s13073-023-01175-6. PMID: 37055795. Laboratory investigation. ˍ

Subbiah V, Kreitman RJ, Wainberg ZA, Gazzah A, Lassen U, Stein A, Wen PY, Dietrich S, de Jonge MJA, Blay JY, Italiano A, Yonemori K, Cho DC, de Vos FYFL, Moreau P, Fernandez EE, Schellens JHM, Zielinski CC, Redhu S, Boran A, Passos VQ, Ilankumaran P, Bang YJ.
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
Nat Med. 2023 Apr 14
. doi: 10.1038/s41591-023-02321-8. PMID: 37059834. Interventional study. ˍ


Kim JE, Park JE, Park SY, Kim YH, Hong CK, Kim JH, Kim HS.
Defining subventricular zone involvement to predict the survival of patients in isocitrate dehydrogenase-wild type glioblastoma: validation in a prospective registry.
Eur Radiol. 2023 Apr 15
. doi: 10.1007/s00330-023-09625-w. PMID: 37060448. Observational study˰ ˍ

Thivat E, Casile M, Moreau J, Molnar I, Dufort S, Seddik K, Le Duc G, De Beaumont O, Loeffler M, Durando X, Biau J.
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).
BMC Cancer. 2023 Apr 15;23(1):344
. doi: 10.1186/s12885-023-10829-y. PMID: 37060055. Interventional study protocol. ˍ